ArticlePostepy dermatologii i alergologii2023

Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience.

Jowita Sroka-Tomaszewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.